%20(2).png){kind=logo}
While the consumerization of healthcare has simplified access to care for lifestyle conditions like acne and hair loss, its impact on more serious conditions, such as cancer, has only recently begun to emerge.
On its 10th anniversary, Exact Sciences' Cologuard, a noninvasive, at-home alternative to colonoscopy, is a prime example of how consumerization can apply to diagnostics. Through convenience and accessibility, Cologuard has been:
(1) used by 16 million patients
(2) detected 525,000 cases of advanced precancerous lesions
(3) identified 42,000 cases of Stage I cancer
(4) saved the US healthcare system $22 billion
Check out Ostro CEO Chase Feiger's latest Forbes article to learn more!
.svg)